Home > 
News
Print

01 June 2005 - Eurogentec takes part in the Universal Vaccine project.


Influenza is a recurrent global threat and affects millions of people in Europe and the world every year. The Universal Vaccine project is highly original and brings together European state-of-the-art scientists in order to develop a powerful new mucosal vaccine for humans providing life-long protection against influenza.

The Universal Vaccine project combines European SMEs and RTD performers that have pioneered the development of new vaccines and vaccine formulations, and which possess unique IPR related to new components and procedures that can be used for safer and more effective vaccination strategies.

Visit the Universal Vaccine website:  http://www.universalvaccine.org/
Back to news list

To receive relevant information on our products, you should first select your country :
Country selection page

Feedback Form